Drug profile · INN
urofollitropin
BRAVELLE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
urofollitropin (BRAVELLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
INN urofollitropin
Brand BRAVELLE
Route INTRAMUSCULAR
Formulation INJECTABLE
Frequently asked questions
What is urofollitropin?
urofollitropin (BRAVELLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for urofollitropin?
BRAVELLE is a marketed brand name for urofollitropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of urofollitropin?
urofollitropin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.